ACE and kidney failure: Whilst there are retrospective data from the European Alport Registry to suggest that ACE inhibitor therapy delays renal failure and improves lifespan, there was agreement that this analysis should be replicated in other registries around the world including large numbers of patients to ensure that it is a consistent finding [18, 19].